Concepedia

Xiaoxia Qian

XQ

Statistics

Publications

17

Citations

1.2K

H-Index

15

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Xiaoxia Qian is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1997–2015

17

Publications

17

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 490 citations · Full text

, , +15

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

Tesfaye Biftu, Ranabir SinhaRoy, Ping Chen et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

, , +14

Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents

Tesfaye Biftu, Dennis Feng, Michael H. Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 97 citations · Full text

, , +8

Chromophore-Modified Bis-Naphthalimides:  Synthesis and Antitumor Activity of Bis-Dibenz[<i>de</i>,<i>h</i>]isoquinoline-1,3-diones

M. F. BRANA, José M. Castellano, Denise Perron et al. · Journal of Medicinal Chemistry · 1997 · 54 citations

, , +15

Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents

Tesfaye Biftu, Dennis Feng, Mitree M. Ponpipom et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 52 citations · Full text

, , +9

1–5 of 17